1. Home
  2. BCLI vs WCT Comparison

BCLI vs WCT Comparison

Compare BCLI & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • WCT
  • Stock Information
  • Founded
  • BCLI 2000
  • WCT 2012
  • Country
  • BCLI United States
  • WCT Hong Kong
  • Employees
  • BCLI N/A
  • WCT 7
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • WCT
  • Sector
  • BCLI Health Care
  • WCT
  • Exchange
  • BCLI Nasdaq
  • WCT NYSE
  • Market Cap
  • BCLI 9.8M
  • WCT 9.7M
  • IPO Year
  • BCLI N/A
  • WCT 2024
  • Fundamental
  • Price
  • BCLI $1.08
  • WCT $0.18
  • Analyst Decision
  • BCLI Strong Buy
  • WCT
  • Analyst Count
  • BCLI 1
  • WCT 0
  • Target Price
  • BCLI $30.00
  • WCT N/A
  • AVG Volume (30 Days)
  • BCLI 473.4K
  • WCT 513.3K
  • Earning Date
  • BCLI 08-13-2025
  • WCT 05-16-2025
  • Dividend Yield
  • BCLI N/A
  • WCT N/A
  • EPS Growth
  • BCLI N/A
  • WCT N/A
  • EPS
  • BCLI N/A
  • WCT N/A
  • Revenue
  • BCLI N/A
  • WCT $2,309,218.00
  • Revenue This Year
  • BCLI N/A
  • WCT N/A
  • Revenue Next Year
  • BCLI N/A
  • WCT N/A
  • P/E Ratio
  • BCLI N/A
  • WCT N/A
  • Revenue Growth
  • BCLI N/A
  • WCT N/A
  • 52 Week Low
  • BCLI $0.72
  • WCT $0.12
  • 52 Week High
  • BCLI $6.45
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 43.20
  • WCT N/A
  • Support Level
  • BCLI $1.08
  • WCT N/A
  • Resistance Level
  • BCLI $1.32
  • WCT N/A
  • Average True Range (ATR)
  • BCLI 0.10
  • WCT 0.00
  • MACD
  • BCLI -0.01
  • WCT 0.00
  • Stochastic Oscillator
  • BCLI 4.00
  • WCT 0.00

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service (SaaS) platforms, and white-label software design and development services.

Share on Social Networks: